Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012

Iranian Journal of Microbiology

Volumn 5, Issue 2, 2013, Pages 172-176

  Ehteram, Hassan ^a   Ramezani, Amitis ^b   Eslamifar, Ali ^b   Sofian, Masoomeh ^c   Banifazl, Mohammad ^d   Ghassemi, Shahin ^e   Aghakhani, Arezoo ^b   Mashayekhi, Parisa ^f  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Departments of Clinical Research   (Iran)

^c ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Iranian Society for Support of Patients with Infectious Diseases   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Blood donor; Hepatitis E Virus (HEV); Seroprevalence

Indexed keywords

HEPATITIS E ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POSTTRANSFUSION HEPATITIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE;

EID: 84878056180     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis 2009; 13: 67-71
2. Keyvani H, Shamsi Shahrabadi M, Najafifard S, Hajibeigi B, Fallahian F, Alavian SM. Seroprevalence of anti-HEV and HEV RNA among volunteer blood donors and patients with Hepatitis B and C in Iran. Bangladesh Liver Journal 2009; 1: 34-37.
3. Ahn J, Kang SG, Lee DY, Shin SJ, Yoo HS. Identification of HEV isolates and determination of the seroprevalence of HEV in Korea. J Clin Microbiol 2005; 43: 3042-3048.
4. Cheng XF, Wen YF, Zhu M, Zhan SW, Zheng JX, Dong C, et al. Serological and molecular study of hepatitis E virus among illegal blood donors. World J Gastroenterol. 2012; 18: 986-990.
5. Fukuda S, Sunaga J, Saito N, Fujimura K, Itoh Y, Sasaki M, et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol 2004; 73: 554-561.
6. Kaufmann A, Kenfak-Foguena A, André C, Canellini G, Bürgisser P, Moradpour D, et al. Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.PLoS One 2011; 6: e21150.
7. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
8. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res 2007; 127: 216-228.
9. Aggarwal R. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review. Geneva, Switzerland: WHO; 2010.
10. Acharya SK, Panda SK. Hepatitis E virus: epidemiology, diagnosis, pathology and prevention.Trop Gastroenterol 2006; 27: 63-68.
11. Yazaki Y, Mizuo H, Takahashi M, Nishizawa T, Sasaki N, Gotanda Y, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food.J Gen Virol 2003; 84: 2351-2357.
12. Tei S, KitajimaN, Takahashi K,Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-373.
13. Arankalle VA, Chobe LP. Hepatitis E virus: Can it be transmitted parenterally? J Viral Hep 1999; 6: 161-164.
14. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: Evidence for posttransfusion hepatitis E. Vox Sang 2000;79: 72-74.
15. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran.East Mediterr Health J 2007; 13: 98-102.
16. Taremi M, Khoshbaten M, Gachkar L, Ehsani Ardakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran.BMC Infect Dis 2005; 5: 36
17. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR. Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study.East Mediterr Health J 2008; 14: 157-1562.
18. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country.Transfus Med 2006; 16: 79-83.
19. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma.Hepatol Res 2007; 37: 113-120.
20. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, et al. A case of transfusiontransmitted hepatitis E caused by blood from a donor infected with hepatitis E virus zoonotic food-borne route.Transfusion 2008; 48: 1368-1375.
21. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran.Int J Infect Dis 2008; 12: 387-390.
22. Aminafshar S, Alimagham M, Gachkar L, Yousefi F, Attarchi Z. Anti-hepatitis E virus seropositivity in a group of blood donors.Iran J Public Health 2004; 33:53-56.
23. Meng XJ. Novel strains of hepatitis E virus identified from humans and other animal species: Is hepatitis E a zoonosis? J Hepatol 2000;33: 842-845.
24. Emerson SU, Purcell RH. Hepatitis E virus.Rev Med Virol 2003; 13: 145-154.
25. Okamoto H, Takahashi M, Nishizawa T. Features of hepatitis E virus infection in Japan.Intern Med 2003; 42: 1065-1071.
26. Alavian SM. Hepatitis E Virus Infection: A Neglected Problem in Our Region. Hepat Mon 2007; 7: 119-121.
27. Safar MJ, Khalilian A, Farhadi R, Babamohmoodi F. Seroepidemiology of HEV infection in 2-25 years of saravi in 2004. J Mazandaran Univ Med Sci 2005; 75: 82-85.
28. Ghadir M, Jafari E, Rezvan H, Amini Kafiabad S, Vahezjavadi M, Pourshams A. Hepatitis A and E in the east of Golestan province.J Med Council IRI 2007; 25: 34-38.
29. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study.Trans R Soc Trop Med Hyg 2012; 106: 528-531.
30. Rezazadeh M, Hahiloui M, Ghachkar L, Iadegari D, Kashani KM, Naghdi M. Study of antibody prevalence against Hepatitis E in blood donors in Hamedan.Infect Trop Dis 2005; 11: 13-18.
31. Gachkar L, Taremi M, Mahmoodarabi S, Kheradpajooh M, Dehkhoda R, Torabi SE. Frequency of antibodies to hepatitis E virus among male blood donors in Tabriz.Blood 2005; 2: 157-162.
32. Zanetti AR, Dawson GJ. Hepatitis typeE in Italy: a seroepidemiological survey. Study Group of Hepatitis E.J Med Virol 1994; 42: 318-320.
33. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark Clin Infect Dis 2008; 47: 1026-1031.
34. Bortoliero AL, Bonametti AM, Morimoto HK, Matsuo T, Reiche EM. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná, Brazil.Rev Inst Med Trop Sao Paulo 2006; 48: 87-92.
35. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, et al. Prevalence of hepatitis E virus in Chinese blood donors.J Clin Microbiol 2010; 48: 317-8.
36. Irani Hakime N, Feghali Haibeh R. HepatitisE virus: detection of antibodies in blood donors in Lebanon.J Med Liban 1998; 46: 60-62.
37. Abdel Hady SI, El-Din MS, El-Din ME. A high hepatitis E virus (HEV) seroprevalence among unpaid blood donors and haemodialysis patients in Egypt. J Egypt Public Health Assoc 1998; 73: 165-179.